Strides receives US FDA approval for 2 drugs
New Delhi, Sep 2 (UNI) Pharmaceutical firm Strides Arcolab today said it has received US Food and Drug Administration (USFDA) approval for its two new drugs used for normalising blood circulation.
The company has received Abbreviated New Drug Application (ANDA) approval for two drugs-- Dexamethasone Injection and Dexamethasone Sodium Phosphate-- from USFDA.
The drugs, used to treat fluid retention and swelling in the brain, normalise blood circulation due to surgical or accidental trauma and also in the treatment of inflammatory disorders like asthma and arthritis.
The products are licenced to Akorn-Strides, a joint venture between Nasdaq-listed Akorn Inc and Strides Arcolab.
The JV has now received 11 ANDA approvals out of the 18 filed till date.
UNI AK SG SSC1201
-
Gold Silver Rate Today, 10 March 2026: City-Wise Prices Edge Lower While MCX Gold And Silver Stay Range-Bound -
Hyderabad To Get Faster Road Link To Indore As New Highway Nears Completion, Opening Likely This Month -
Hyderabad Gold Silver Rate Today, 10 March 2026: Gold, Silver Slip In Local Market; MCX Also Trades Lower -
Oil Slumps 6% As Trump Claims Iran War Will Be Over 'Ahead of Schedule' -
Pune Gold Rate Today For 18K, 22K, 24K For Rates March 2026 -
Bangalore Gold Silver Rate Today, March 10, 2026: Gold and Silver Prices Go Up -
IPL 2026 Schedule Announcement On March 12: BCCI to Release First 20 Days of Indian Premier League Fixtures -
IPL 2026 Playing XI Prediction: CSK, MI, RCB, KKR, PBKS, GT, LSG, DC, RR, SRH Impact Sub & Full Team List -
Chennai Hotels Warn of Shutdown In 2 Days As LPG Supply Crunch Hits TN -
Trisha Shouldn't Have Attended The Event With Vijay: Parthiban -
Pakistan Facing Oil Crisis? PM Orders Shutdown Of Schools And Universities, Introduces 4-Day Workweek -
Flight Ticket Prices To Turn Costly Due To Iran Crisis? SpiceJet Chief Hints At Airfare Hike
Click it and Unblock the Notifications
Sign in with Google